SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001477932-19-002827
Filing Date
2019-05-15
Accepted
2019-05-15 17:13:05
Documents
1
Period of Report
2019-03-31
Effectiveness Date
2019-05-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q curr_nt10q.htm NT 10-Q 17309
  Complete submission text file 0001477932-19-002827.txt   18425
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 19829576
SIC: 2673 Plastics, Foil & Coated Paper Bags